SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Allergan Inc. Quietly Leases A 90,000 Square Feet Space In Texas
October 1, 2014
 · 
2 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Lone Star Bio
CDC Confirms First American Ebola Case In Dallas
October 1, 2014
 · 
2 min read
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
Lone Star Bio
Analysts Say ZS Pharma Continues To Gain On Drug Approval
September 26, 2014
 · 
1 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Lone Star Bio
Nanotubes Help Healing Hearts Keep The Beat, Rice University Study
September 25, 2014
 · 
5 min read
How To Land The Perfect R&D Job: A Q&A With Luminex
Lone Star Bio
How To Land The Perfect R&D Job: A Q&A With Luminex Corporation
September 24, 2014
 · 
1 min read
Biotech Boom On Third Coast Proves Everything's Bigger In Texas
Lone Star Bio
Biotech Boom On Third Coast Proves Everything’s Bigger In Texas
September 23, 2014
 · 
6 min read
Top 12 Hot BioPharma Regions For Growth And Expansion
BioCapital
Top 12 Hot BioPharma Regions For Growth And Expansion
September 23, 2014
 · 
12 min read
BioPharm Executive: Building Biotech's Next Boom
Biotech Bay
BioPharm Executive: Building Biotech’s Next Boom
September 22, 2014
 · 
5 min read
Biotech Layoffs Often Go Hand-In-Hand With CEO Pay Raises
Biotech Bay
Biotech Layoffs Often Go Hand-In-Hand With CEO Pay Raises
September 21, 2014
 · 
7 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Lone Star Bio
How You Pick Romantic Partners Could Be A Matter Of Tiny Words, University of Texas Study
September 17, 2014
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 26, 2026
 · 
6 min read
Press Releases
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
June 26, 2026
 · 
11 min read
Press Releases
DecisionDx®-Melanoma’s i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy
June 25, 2026
 · 
10 min read
Press Releases
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
June 25, 2026
 · 
7 min read
Press Releases
Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
June 25, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
June 25, 2026
 · 
3 min read
Press Releases
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
June 25, 2026
 · 
5 min read
Press Releases
Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026
June 24, 2026
 · 
5 min read
Press Releases
Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer
June 24, 2026
 · 
5 min read
Press Releases
Susan G. Komen® Awards $15.4 Million In Research Grants to Accelerate Breakthroughs in Breast Cancer Care
June 24, 2026
 · 
6 min read
Load More